Two breakthroughs in CGD studies

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Studies in Chronic Granulomatous Disease showed two breakthroughs during this past decade. First, the discovery of 7 Nox/Duox family proteins, Noxo1and Noxa1 (homologues of gp91phox, p47phox and p67phox) may clarify novel physiological mechanisms for superoxide regulation in various organs, such as the regulation of blood pressure, mucosal defense system in respiratory/digestive tract and nephron. Secondly, the success in bone marrow transplantation and gene therapy for CGD should facilitate treatment for other genetic diseases as well. © 2007, The Japan Society for Clinical Immunology. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Nunoi, H. (2007). Two breakthroughs in CGD studies. Japanese Journal of Clinical Immunology, 30(1), 1–10. https://doi.org/10.2177/jsci.30.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free